Analyst Signal

Pfizer, Inc. (PFE) is currently trading at $28.32. Based on 26 Wall Street analysts, the average target price is $28.58, implying a 0.9% upside. The consensus recommendation is BUY.

PFE

Pfizer, Inc.

HealthcareOpinion: buy

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$28.32

Avg Target

$28.58

Based on 26 analysts

Analyst Recommendations

Buy (10)Hold (15)Sell (3)

Upside

+0.92%

Market Cap

$161.09B

Financial & Investment Metrics

Next Earnings Date
May 5, 2026D-32
P/E Ratio (TTM)20.82
Forward P/E10.03
P/B Ratio1.86
Dividend Yield6.07%
Return on Equity (ROE)8.89%
Operating Margin23.95%
Debt to Equity77.96
Beta (Volatility)0.41
52 Week Range$20.92 - $28.75
LowCurrent: $28.32High

Insider Sentiment Index (Last 6 Months)

Buy vs Sell (Count)

Insider Buys: 0Insider Sells: 0

Whale Trades (C-Level Large Buys)

No major insider buying detected recently.

Frequently Asked Questions

Q. What is the current target price and upside for PFE?

A. The current target price for Pfizer, Inc. is $28.58, which implies a 0.9% upside from the current price of $28.32. This is based on the consensus of 26 Wall Street analysts.

Q. What is the current analyst recommendation for PFE?

A. Currently, there are 2 Strong Buy, 8 Buy, 15 Hold, 1 Sell, and 2 Strong Sell ratings. The overall consensus is BUY.

Q. Are insiders buying PFE stock recently?

A. Over the past 6 months, there have been 0 insider buys and 0 insider sells. Insider selling is more prominent recently.

Other Promising Stocks in Healthcare

PFE (Pfizer, Inc.) Stock Analysis | Analyst Signal